Commentary on H. Ide et al., "Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells"

Biochem Biophys Res Commun. 2008 Feb 22;366(4):869-70. doi: 10.1016/j.bbrc.2007.12.017. Epub 2007 Dec 17.

Authors

Christian Schuster¹, Mathias Müller, Michael Freissmuth, Veronika Sexl, Dagmar Stoiber

Affiliation

¹ Department of Pharmacology, Medical University of Vienna, Waehringerstrasse 13A, A-1090 Vienna, Austria.

PMID: 18082134
DOI: 10.1016/j.bbrc.2007.12.017

No abstract available

MeSH terms

Animals
Burkitt Lymphoma / enzymology
Humans
Liver / drug effects
Liver / enzymology
Liver / pathology
Male
Mice
Neoplasm Invasiveness
Prostatic Neoplasms / enzymology*
Prostatic Neoplasms / pathology*
Protein Kinase Inhibitors / pharmacology
Signal Transduction* / drug effects
TYK2 Kinase / antagonists & inhibitors
TYK2 Kinase / metabolism*

Substances

Protein Kinase Inhibitors
TYK2 Kinase